| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Labcorp Holdings Inc. (LH) has 24 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. LH is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 107.2K | $27.33M | - | |
| VP | 36.5K | $9.30M | - | |
| COO | 12.7K | $3.23M | - | |
| VP | 7.9K | $2.01M | - | |
| VP | 6.7K | $1.72M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 3,897 | $225.81 | $879,981.57 | -36.8% | +5.2% | +10.1% | |
| Feb 21, 2023 | Kirchgraber Paul R | CEO, Covance Drug Development | Sale+OE | 8,000 | $250.58 | $2,004,675.20 | -46.9% | -11.1% | +3.2% | |
| Feb 14, 2023 | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 309 | $247.63 | $76,517.67 | -4.4% | -8.3% | +9.6% | |
| Feb 7, 2023 | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 409 | $243.01 | $99,391.09 | -5.8% | -9.7% | +6.0% | |
| Feb 7, 2023 | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sell | 219 | $243.01 | $53,219.19 | -3.9% | -9.7% | +6.0% | |
| Feb 3, 2023 | Van Der Vaart Sandra D60 | EVP, Chief Legal Officer | Sale+OE | 173 | $253.90 | $43,924.70 | -3.1% | -10.8% | +4.1% | |
| Feb 3, 2023 | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sale+OE | 324 | $253.90 | $82,263.60 | -4.6% | -10.8% | +4.1% | |
| Nov 8, 2022 | Schroeder Mark S56 | EVP, President-diagnostics Lab | Sell | 1,116 | $232.67 | $259,659.72 | -14.3% | +4.1% | +2.6% | |
| Sep 26, 2022 | Eisenberg Glenn A | Chief Financial Officer, EVP | Sell | 25,000 | $210.62 | $5,265,576.18 | -14.7% | +11.0% | +14.6% | |
| Sep 7, 2022 | Caveney Brian J | EVP, President Of Diagnostics | Buy | 44 | $231.20 | $10,250.96 | +0.3% | +1.2% | +4.0% |